Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Take 5 Oil Change Grows Its Presence in Durham, North Carolina to Meet Demand for Convenient Car Care

April 23, 2026

Bitget Partners with Market Prophit to Expand Data-Driven Social Trading Capabilities

April 23, 2026

AriseAlpha Expands Free AI Stock Trading Bot to Support Faster Passive Income in 2026

April 23, 2026

The Center for Cancer and Blood Disorders receives authorization to administer FDA-approved CAR T-cell therapy; begins treating first community oncology patient in Maryland-area clinic

April 23, 2026

Biologics Active Pharmaceutical Ingredient (API) Market Worth $101.8 Billion by 2030, Witnessing 8.8% CAGR

April 23, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Centuri Holdings
Press Release

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Centuri Holdings

By News RoomJuly 31, 20242 Mins Read
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Centuri Holdings
Share
Facebook Twitter LinkedIn Pinterest Email

If you suffered significant losses in Centuri stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/CTRI.


NEW YORK, July 31, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Centuri Holdings, Inc. (“Centuri” or the “Company”) (NYSE: CTRI).

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

On July 29, 2024, Centuri reported its financial results for the second quarter, revealing a Non-GAAP Earnings Per Share of $0.20, which falls short by $0.02 in comparison to market expectations. Additionally, the company’s revenue for the quarter was disclosed at $643.39 million, representing a year-over-year decline of 17.0% and missing analyst projections by $117.03 million.

Centuri conducted its initial public offering just months earlier on April 18, 2024, and the company sold 12.4 million shares for $21. Since then, the stock has plummeted, and on July 29, 2024, Centuri stock closed at $15.72.

To learn more about the Centuri investigation, go to www.faruqilaw.com/CTRI or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

A photo accompanying this announcement is available at: 
https://www.globenewswire.com/NewsRoom/AttachmentNg/5e848124-9c14-4bab-ba13-256ecec0c433

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Take 5 Oil Change Grows Its Presence in Durham, North Carolina to Meet Demand for Convenient Car Care

Bitget Partners with Market Prophit to Expand Data-Driven Social Trading Capabilities

AriseAlpha Expands Free AI Stock Trading Bot to Support Faster Passive Income in 2026

The Center for Cancer and Blood Disorders receives authorization to administer FDA-approved CAR T-cell therapy; begins treating first community oncology patient in Maryland-area clinic

Biologics Active Pharmaceutical Ingredient (API) Market Worth $101.8 Billion by 2030, Witnessing 8.8% CAGR

Polyphenylene Sulfide (PPS) Market Projected to Hit $2.9 Billion by 2032 – PPS Compounds Dominate, Driving Automotive and Aerospace Demand

Wärtsilä continues to expand its data center footprint with new 790 MW order in Texas, the next Data Center Alley

Liquid Crystal Polymers (LCP) Market Review and Growth Forecast 2022-2032 – Asia-Pacific Dominated with 84% Share in 2025; Projected to Reach 73 Thousand Metric Tons by 2032

Women Are Ditching Generic Diets for Cycle-Based Wellness – This Cycle Diet App Review Explains Why

Editors Picks

Bitget Partners with Market Prophit to Expand Data-Driven Social Trading Capabilities

April 23, 2026

AriseAlpha Expands Free AI Stock Trading Bot to Support Faster Passive Income in 2026

April 23, 2026

The Center for Cancer and Blood Disorders receives authorization to administer FDA-approved CAR T-cell therapy; begins treating first community oncology patient in Maryland-area clinic

April 23, 2026

Biologics Active Pharmaceutical Ingredient (API) Market Worth $101.8 Billion by 2030, Witnessing 8.8% CAGR

April 23, 2026

Latest News

Polyphenylene Sulfide (PPS) Market Projected to Hit $2.9 Billion by 2032 – PPS Compounds Dominate, Driving Automotive and Aerospace Demand

April 23, 2026

Hamilton police search for man accused of escaping custody

April 23, 2026

Wärtsilä continues to expand its data center footprint with new 790 MW order in Texas, the next Data Center Alley

April 23, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version